Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Open-Label Treatment Extension of Protocol MNTX 302

This study has been completed.
Information provided by:
Valeant Pharmaceuticals International, Inc. Identifier:
First received: May 27, 2011
Last updated: July 18, 2011
Last verified: July 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2006
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)